Beam Therapeutics Inc. (BEAM)

Beam Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	527.91	281.97	435.9	232.77	559.99	162.17
Short-Term Investments	692.05	568.77	753.98	845.37	405.65	137.5
Cash & Short-Term Investments	1,220	850.74	1,190	1,078	965.65	299.67
Cash Growth	11.46%	-28.50%	10.36%	11.65%	222.24%	226.27%
Receivables	-	-	-	-	300	-
Prepaid Expenses	27.66	27.41	21.17	14.76	7.36	8.65
Total Current Assets	1,248	878.15	1,211	1,093	1,273	308.32
Property, Plant & Equipment	211.79	216.28	237.81	234.13	186.98	125.37
Other Long-Term Assets	7.52	9.4	10.87	14.69	14.47	17.98
Total Assets	1,467	1,104	1,460	1,342	1,474	451.68
Accounts Payable	7.7	3.87	1.62	9.03	7.47	6.31
Accrued Expenses	22.32	36.13	35.05	30.72	56.87	11.96
Current Portion of Leases	13.21	13.47	12.78	12.23	9.83	6.34
Current Unearned Revenue	85.2	108.86	68.71	135.97	86.27	0.02
Other Current Liabilities	13.12	19.74	87.42	35.64	53	77.7
Total Current Liabilities	141.55	182.07	205.57	223.6	213.44	102.34
Long-Term Leases	144.92	147.96	159.91	168.63	137.82	101.31
Long-Term Unearned Revenue	49.4	33.22	109.89	202.18	262.3	0.39
Other Long-Term Liabilities	7.92	7.04	3.02	13.84	34.16	2.08
Total Liabilities	343.78	370.28	478.39	608.24	647.72	206.12
Common Stock	1.01	0.84	0.82	0.71	0.68	0.57
Additional Paid-In Capital	2,798	2,299	2,170	1,793	1,594	642.63
Retained Earnings	-1,676	-1,567	-1,190	-1,057	-768.27	-397.64
Comprehensive Income & Other	0.16	0.68	0.6	-2.43	-0.05	-0.01
Total Common Equity	1,123	733.55	981.33	733.47	826.74	245.56
Shareholders' Equity	1,123	733.55	981.33	733.47	826.74	245.56
Total Liabilities & Equity	1,467	1,104	1,460	1,342	1,474	451.68
Total Debt	158.13	161.43	172.69	180.86	147.64	107.64
Net Cash (Debt)	1,062	689.32	1,017	897.28	818	192.03
Net Cash Growth	14.61%	-32.23%	13.36%	9.69%	325.98%	216.82%
Net Cash Per Share	12.66	8.37	13.18	12.82	12.74	4.11
Filing Date Shares Outstanding	97.49	81.11	78.73	70.7	67.6	61.14
Total Common Shares Outstanding	97.49	81.06	78.71	69.58	67.26	55.98
Working Capital	1,106	696.08	1,005	869.3	1,060	205.98
Book Value Per Share	11.52	9.05	12.47	10.54	12.29	4.39
Tangible Book Value	1,123	733.55	981.33	733.47	826.74	245.56
Tangible Book Value Per Share	11.52	9.05	12.47	10.54	12.29	4.39
Machinery	82.02	79.79	69.67	54.79	35.23	18.83
Construction In Progress	3.97	2.53	5.28	5.2	7.35	15.88
Leasehold Improvements	101.22	101.2	100.19	85.8	57.76	12.71

Updated Feb 25, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q